Illumina, Inc. et al v. QIAGEN, N.V. et al

Filing 165

STIPULATION AND ORDER REGARDING PATENT DISCLOSURES AND CLAIM CONSTRUCTION by Hon. William Alsup granting 164 Stipulation.(whalc1, COURT STAFF) (Filed on 12/13/2016)

1
2
3
4
5
6
7
8
9
10
11
12
13

John L. Cooper (SBN 50324)
[e-mail]
Jeffrey M. Fisher (SBN 155284)
[e-mail]
Winston Liaw (State Bar No. 273899)
[e-mail]
FARELLA BRAUN & MARTEL LLP
235 Montgomery Street, 17th Floor
San Francisco, California 94104
Telephone: [phone]
Facsimile: [phone]

Edward R. Reines (SBN 135960)
[e-mail]
Derek C. Walter (SBN 246322)
[e-mail]
WEIL, GOTSHAL & MANGES LLP
201 Redwood Shores Parkway
Redwood Shores, California 94065
Telephone: [phone]
Facsimile: [phone]
Attorneys for Plaintiffs Illumina, Inc. and
Illumina Cambridge Ltd.

Robert R. Baron, Jr. (PA SBN 67084)
(appearance pro hac vice)
[e-mail]
Marc S. Segal (PA SBN 84474)
(appearance pro hac vice)
[e-mail]
Tyler R. Marandola (PA SBN 313585)
(appearance pro hac vice)
[e-mail]
BALLARD SPAHR LLP
1735 Market Street, 51st Floor
Philadelphia, PA 19103-7599
Telephone: [phone]
Facsimile: [phone]

14
15
16

Attorneys for Defendants QIAGEN, N.V.,
QIAGEN GmbH, QIAGEN Gaithersburg, Inc.,
QIAGEN Sciences, LLC, QIAGEN Inc. (USA),
QIAGEN Redwood City, Inc., and
Intelligent Bio-Systems, Inc.

17
UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA
SAN FRANCISCO DIVISION

18
19
20
21

ILLUMINA, INC.
ILLUMINA CAMBRIDGE LTD.,
Plaintiffs,

22
23
24
25
26

vs.

Case No. 16-cv-02788-WHA
STIPULATION AND [PROPOSED]
ORDER REGARDING PATENT
DISCLOSURES AND CLAIM
CONSTRUCTION

QIAGEN N.V., QIAGEN GmbH,
QIAGEN GAITHERSBURG, INC.,
QIAGEN SCIENCES, LLC,
QIAGEN INC. (USA), QIAGEN
REDWOOD CITY, INC., and
INTELLIGENT BIO-SYSTEMS, INC.,

27
Defendants.
28
Farella Braun + Martel LLP
235 Montgomery Street, 17th Floor
San Francisco, CA 94104
[phone]

STIP/ORDER RE PATENT DISCLOSURES,
CLAIM CONSTRUCTION; Case No. 16-cv-02788WHA

33250\5478349.1

1

WHEREAS, on May 24, 2016, Illumina, Inc. and Illumina Cambridge Ltd. (collectively,

2

“Illumina”) filed its Complaint [Dkt. No. 1] against defendants QIAGEN N.V., QIAGEN GmbH,

3

QIAGEN Gaithersburg, Inc., QIAGEN Sciences, LLC, QIAGEN Inc. (USA), QIAGEN Redwood

4

City, Inc., and Intelligent Bio-Systems, Inc. (collectively, “QIAGEN”) asserting U.S. Patent No.

5

7,566,537 (“the ’537 Patent”);

6

WHEREAS, on November 29, 2016, the Court granted Plaintiffs Illumina Inc., and

7

Illumina Cambridge Ltd.’s (collectively “Illumina”) motion to supplement its complaint to assert

8

claims for infringement of U.S. Patent No. 9,410,200 (“the ’200 Patent”) [Dkt. No. 162];

9
10
11

WHEREAS, the parties believe that it will be most efficient to synchronize the patent
disclosures and claim construction proceedings for both the ’537 and ’200 Patents;
NOW THEREFORE, the parties HEREBY STIPULATE AND AGREE, subject to the

12

approval and order of the Court, to the following amended schedule for the patent disclosures and

13

claim construction proceedings:

14

NOW THEREFORE, the parties HEREBY STIPULATE AND AGREE, subject to the

15

approval and order of the Court, to the following schedule for the completion of the patent

16

disclosures and claim construction proceedings:

17
18
19
20
21

1.

Illumina will serve supplemental infringement contentions that include allegations

regarding the ’200 Patent under Patent L.R. 3-1 and 3-2 on December 16, 2016.
2.

QIAGEN will serve supplemental invalidity contentions that include allegations

regarding the ’200 Patent under Patent L.R. 3-4 and 3-5 on January 6, 2017.
3.

The parties will exchange an updated, supplemental list of proposed claim terms

22

for construction that include terms from both the ’537 and ’200 Patents under Patent L.R. 4-1 on

23

January 13, 2017.

24
25
26
27

4.

The parties will exchange proposed preliminary claim constructions for both the

’537 and ’200 Patents under Patent L.R. 4-2 on January 20, 2017.
5.

The parties shall file a Joint Claim Construction and Prehearing Statement under

Patent L.R. 4-3 on February 3, 2017.

28
Farella Braun + Martel LLP
235 Montgomery Street, 17th Floor
San Francisco, CA 94104
[phone]

STIP/ORDER RE PATENT DISCLOSURES,
CLAIM CONSTRUCTION; Case No. 16-cv-02788WHA

-2-

33250\5478349.1

1

6.

2

Patent L.R. 4-5.

The completion of claim construction briefing will be according to schedule under

3
4

IT IS SO STIPULATED.

5
6
7
8
9

Dated: December 12, 2016

FARELLA BRAUN & MARTEL LLP

I, John L. Cooper, represent that
concurrence in the filing of this
document has been obtained from
the other signatory, which shall
serve in lieu of his signature on this
document.

/s/ John L. Cooper
John L. Cooper
Attorneys For Defendants
QIAGEN, N.V., QIAGEN GMBH, QIAGEN
GAITHERSBURG, INC., QIAGEN SCIENCES,
LLC, QIAGEN INC. (USA), QIAGEN
REDWOOD CITY, INC., AND INTELLIGENT
BIO-SYSTEMS, INC.

10
11
12
13

WEIL, GOTSHAL & MANGES LLP

14

/s/ Edward R. Reines
Edward R. Reines

15

Attorneys for Plaintiffs
ILLUMINA, INC. AND ILLUMINA
CAMBRIDGE LTD.

16
17
18

[PROPOSED] ORDER

19
20
21
22

PURSUANT TO STIPULATION, IT IS SO ORDERED.
IT IS SO ORDERED.
December 13, 2016.
Dated: ___________________

HON. WILLIAM ALSUP
UNITED STATES DISTRICT JUDGE

23
24
25
26
27
28
Farella Braun + Martel LLP
235 Montgomery Street, 17th Floor
San Francisco, CA 94104
[phone]

STIP/ORDER RE PATENT DISCLOSURES,
CLAIM CONSTRUCTION; Case No. 16-cv-02788WHA

-3-

33250\5478349.1